Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease. The lack of targeted therapies and poor patient outcome have fostered efforts to discover new molecular targets to treat patients with TNBC. Here, we showed that baculoviral IAP repeat containing 6 (BIRC6) is overexpres...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yongpeng, Tan, Yanan, Wen, Lijuan, Xing, Zhihao, Wang, Changxu, Zhang, Liuhui, Wu, Kai, Sun, Haiyan, Li, Yuqing, Lei, Qifang, Wu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526501/
https://www.ncbi.nlm.nih.gov/pubmed/34729249
http://dx.doi.org/10.1016/j.omtn.2021.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526501/
https://www.ncbi.nlm.nih.gov/pubmed/34729249
http://dx.doi.org/10.1016/j.omtn.2021.09.011

Ejemplares similares